These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 33784417)

  • 1. Upregulation of CCR4 in activated CD8
    Spoerl S; Kremer AN; Aigner M; Eisenhauer N; Koch P; Meretuk L; Löffler P; Tenbusch M; Maier C; Überla K; Heinzerling L; Frey B; Lutzny-Geier G; Winkler TH; Krönke G; Vetter M; Bruns H; Neurath MF; Mackensen A; Kremer AE; Völkl S
    Eur J Immunol; 2021 Jun; 51(6):1436-1448. PubMed ID: 33784417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.
    Sánchez-Cerrillo I; Landete P; Aldave B; Sánchez-Alonso S; Sánchez-Azofra A; Marcos-Jiménez A; Ávalos E; Alcaraz-Serna A; de Los Santos I; Mateu-Albero T; Esparcia L; López-Sanz C; Martínez-Fleta P; Gabrie L; Del Campo Guerola L; de la Fuente H; Calzada MJ; González-Álvaro I; Alfranca A; Sánchez-Madrid F; Muñoz-Calleja C; Soriano JB; Ancochea J; Martín-Gayo E;
    J Clin Invest; 2020 Dec; 130(12):6290-6300. PubMed ID: 32784290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
    Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
    Front Immunol; 2020; 11():596553. PubMed ID: 33324414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1-Expressing SARS-CoV-2-Specific CD8
    Rha MS; Jeong HW; Ko JH; Choi SJ; Seo IH; Lee JS; Sa M; Kim AR; Joo EJ; Ahn JY; Kim JH; Song KH; Kim ES; Oh DH; Ahn MY; Choi HK; Jeon JH; Choi JP; Kim HB; Kim YK; Park SH; Choi WS; Choi JY; Peck KR; Shin EC
    Immunity; 2021 Jan; 54(1):44-52.e3. PubMed ID: 33338412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?
    Berthelot JM; Lioté F; Maugars Y; Sibilia J
    Front Immunol; 2020; 11():607069. PubMed ID: 33335532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-inflammatory microenvironment and systemic accumulation of CXCR3+ cell exacerbate lung pathology of old rhesus macaques infected with SARS-CoV-2.
    Zheng HY; He XY; Li W; Song TZ; Han JB; Yang X; Liu FL; Luo RH; Tian RR; Feng XL; Ma YH; Liu C; Li MH; Zheng YT
    Signal Transduct Target Ther; 2021 Sep; 6(1):328. PubMed ID: 34471088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally activated adaptive immunity in COVID-19 patients.
    Yang X; Dai T; Zhou X; Qian H; Guo R; Lei L; Zhang X; Zhang D; Shi L; Cheng Y; Hu J; Guo Y; Zhang B
    J Cell Mol Med; 2020 Nov; 24(21):12457-12463. PubMed ID: 32975374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique immunological profile in patients with COVID-19.
    Varchetta S; Mele D; Oliviero B; Mantovani S; Ludovisi S; Cerino A; Bruno R; Castelli A; Mosconi M; Vecchia M; Roda S; Sachs M; Klersy C; Mondelli MU
    Cell Mol Immunol; 2021 Mar; 18(3):604-612. PubMed ID: 33060840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of T lymphocytes in severe COVID-19 patients.
    Fenoglio D; Dentone C; Parodi A; Di Biagio A; Bozzano F; Vena A; Fabbi M; Ferrera F; Altosole T; Bruzzone B; Giacomini M; Pelosi P; De Maria A; Bassetti M; De Palma R; Filaci G
    J Med Virol; 2021 Sep; 93(9):5608-5613. PubMed ID: 33913544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune signatures underlying post-acute COVID-19 lung sequelae.
    Cheon IS; Li C; Son YM; Goplen NP; Wu Y; Cassmann T; Wang Z; Wei X; Tang J; Li Y; Marlow H; Hughes S; Hammel L; Cox TM; Goddery E; Ayasoufi K; Weiskopf D; Boonyaratanakornkit J; Dong H; Li H; Chakraborty R; Johnson AJ; Edell E; Taylor JJ; Kaplan MH; Sette A; Bartholmai BJ; Kern R; Vassallo R; Sun J
    Sci Immunol; 2021 Nov; 6(65):eabk1741. PubMed ID: 34591653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
    Zhou R; To KK; Wong YC; Liu L; Zhou B; Li X; Huang H; Mo Y; Luk TY; Lau TT; Yeung P; Chan WM; Wu AK; Lung KC; Tsang OT; Leung WS; Hung IF; Yuen KY; Chen Z
    Immunity; 2020 Oct; 53(4):864-877.e5. PubMed ID: 32791036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Nguyen THO; Rowntree LC; Petersen J; Chua BY; Hensen L; Kedzierski L; van de Sandt CE; Chaurasia P; Tan HX; Habel JR; Zhang W; Allen LF; Earnest L; Mak KY; Juno JA; Wragg K; Mordant FL; Amanat F; Krammer F; Mifsud NA; Doolan DL; Flanagan KL; Sonda S; Kaur J; Wakim LM; Westall GP; James F; Mouhtouris E; Gordon CL; Holmes NE; Smibert OC; Trubiano JA; Cheng AC; Harcourt P; Clifton P; Crawford JC; Thomas PG; Wheatley AK; Kent SJ; Rossjohn J; Torresi J; Kedzierska K
    Immunity; 2021 May; 54(5):1066-1082.e5. PubMed ID: 33951417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
    Rébillard RM; Charabati M; Grasmuck C; Filali-Mouhim A; Tastet O; Brassard N; Daigneault A; Bourbonnière L; Anand SP; Balthazard R; Beaudoin-Bussières G; Gasser R; Benlarbi M; Moratalla AC; Solorio YC; Boutin M; Farzam-Kia N; Descôteaux-Dinelle J; Fournier AP; Gowing E; Laumaea A; Jamann H; Lahav B; Goyette G; Lemaître F; Mamane VH; Prévost J; Richard J; Thai K; Cailhier JF; Chomont N; Finzi A; Chassé M; Durand M; Arbour N; Kaufmann DE; Prat A; Larochelle C
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33635833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
    Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
    Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
    Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compartmental immunophenotyping in COVID-19 ARDS: A case series.
    Ronit A; Berg RMG; Bay JT; Haugaard AK; Ahlström MG; Burgdorf KS; Ullum H; Rørvig SB; Tjelle K; Foss NB; Benfield T; Marquart HV; Plovsing RR
    J Allergy Clin Immunol; 2021 Jan; 147(1):81-91. PubMed ID: 32979342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis.
    Kalfaoglu B; Almeida-Santos J; Tye CA; Satou Y; Ono M
    Front Immunol; 2020; 11():589380. PubMed ID: 33178221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Priming of SARS-CoV-2-Specific Naive CD8
    Gallerani E; Proietto D; Dallan B; Campagnaro M; Pacifico S; Albanese V; Marzola E; Marconi P; Caputo A; Appay V; Gavioli R; Nicoli F
    Front Immunol; 2021; 12():693054. PubMed ID: 34326844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.